NL-OMON28054招募中不适用
Multicenter phase I/IIa study using T-cell receptor gene therapy in metastatic melanoma.
KI-AV0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients must be ≥ 18 years of age;
- •2. Patients must have inoperable stage IIIc or stage IV cutaneous melanoma (AJCC) progressing after at least two lines of therapy (DTIC, BRAF inhibitor, ipilimumab);
排除标准
- •1. Life expectancy of less than three months;
- •2. Patients with metastatic ocular melanoma or mucosal melanoma;
研究者
相似试验
已完成
2 期
Multicenter phase I/IIa study using T-cell receptor gene therapy in metastatic melanomamaligne melanomauveal melanoma1003005410040900skin cancerNL-OMON47165ederlands Kanker Instituut20
进行中（未招募）
不适用
A study of gene therapy in patients with metastatic melanomaMedDRA version: 14.1Level: PTClassification code 10025671Term: Malignant melanoma stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MelanomaEUCTR2011-002941-36-NLKI-AV25
进行中（未招募）
1 期
A multicenter phase I/II study for the use of infusions of donor memory T cells after haploidentical stem cell transplantation with TCRaß and CD19-depleted stem cells.EUCTR2022-001080-27-DEniversity Hospital Tuebingen60
终止
1 期
Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell TransplantRecurrent Adult Acute Myeloid LeukemiaRecurrent Childhood Acute Myeloid LeukemiaSecondary Acute Myeloid LeukemiaTherapy-Related Acute Myeloid LeukemiaDonorHematopoietic Cell Transplant RecipientHLA-A*0201 Positive Cells PresentRecurrent Acute Myeloid LeukemiaNCT01640301Fred Hutchinson Cancer Center47
尚未招募
1 期
Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)CoronavirusSARS-CoV-2 InfectionCOVID-19NCT05633446Gylden Pharma Ltd110